The $63 billion takeover of Pharmaceutical Headlines AbbVie has finally ruled to spin off three drugs

(2020/09/07) Volunteers say: What kind of experience is it to finish two injections of domestic new crown vaccine; read the market article of Internet medical investment strategy; U.S. scientists develop dual-specific CAR-T challenge HIV functional cure; health insurance big reform drugstores don't miss these opportunities... The FTC recently approved a final ruling to settle allegations that AbbVie's $63 billion acquisition of Algen would violate federal antitrust laws after three drugs were stripped of their shares after a period of public comment.
's final ruling requires Abel and Aer Lingis to spin off two of Aer Lingin's commercially available pancrease preparations, Zenpep and Viokase, to Nestle, and to spin off Aer Lingin's rights and assets related to Brazikumab to AstraZeneta.
Brazikumab is an IL-23 inhibitor that is currently being clinically developed to treat moderate to severe Crohn's disease and ulcerative colitis.
headlines: Abel and AerGem jointly controlled 95 percent of the drug's market share.
Chinese medicine, Red Day Pharmaceutical formula particles sold 5.7 billion! In 2020, the new crown epidemic is ravaging the world, and the global economic situation under the impact of the epidemic is changing profoundly.
Chinese medicine has played an important role in the whole process of domestic epidemic control, once again showing Chinese wisdom.
On the other hand, with the third batch of national collection and successful opening of tenders, generic drug price reduction tide is becoming more and more intense, collection normalization has been the general trend, the future of biological medicine, traditional Chinese medicine may be included, in such a wave of channels, Chinese medicine formula particles, Chinese medicine tablets have become a hard rock in the market.
headline bacteria: Xiang Xue pharmaceutical impact drink tablets leader throne.
"Eight o'clock health" volunteers to describe: after two injections of domestic new crown vaccine is what kind of experience "drive home suddenly a little dizzy, there is a feeling of drunk driving", September 2, cultural historians, time commentators ten years of wood cutting such a description of his feelings after the new crown vaccine.
more than 20,000 volunteers in China have been vaccinated against the new crown, and cutting wood in a decade is one of them.
: Vaccines bring hope.
the same is true for China's Internet healthcare industry, where outbreaks and health insurance access have brought major changes to the industry.
year, china's Internet medical development has been a decade, which has a budding, there is fanaticism, there are troughs, there is a rise, and now is an unprecedented opportunity.
with the ups and downs of the industry are the participants, those left behind after the sands, from small lotus sharp corners to today's various sub-sectors of unicorns.
past decade, what are the opportunities for Internet healthcare in China at this point in 2020? What kind of change will it bring? How much energy will change generate and how much market space will it create? Headline bacteria: China's pharmaceutical e-commerce market size ceiling of about 861.4 billion.
(Xinhua) -- U.S. scientists developing a dual-specific CAR-T challenge for functional cures for HIV On August 31, Nature Medicine published a new study in collaboration with research institutions such as Harvard Medical School, the Ragon Institute, and the Perelman School of Medicine at the University of Pennsylvania, presenting a new twin-specific CAR-T cell immunotherapy.
This engineered CAR-T cell can reduce viralemia after HIV infection, has the characteristics of strong proliferation, resistance to T cell depletion, and can accelerate the suppression of HIV in combination with antiretroviral therapy, reduce the viral burden of tissue.
: More than 35 million people worldwide are infected with HIV.
"Saibai Blue" hospital was posted a report letter has been drug companies have been suspended recently, there are reports that a number of sanjia hospitals in a number of places were posted anonymous report letter, are related to drug rebates.
The report letter refers directly to the abnormal sales relationship between doctors and medical representatives in some departments of the hospital, from which gold is sold, and the whistleblower said that the relevant situation has been sent to the provincial inspection team, the municipal discipline inspection committee, the hospital leadership office and other relevant units.
, according to industry sources, in response to the relevant reports, hospital procurement staff are being investigated, there are pharmaceutical companies have been suspended.
headlines: It's time for medical representatives to make a big transition.
a great year for pharmacy managers, especially for the pharmacy industry, and don't miss these opportunities.
first half of the fight against the epidemic, has not had time to catch his breath, the second half of the medical reform brought pain and pressure.
the national medical reform into the deep water area, when the third batch of collection list Ofana non-winning bid price is actually as low as 2.08 yuan a piece, which indicates that drug parity is approaching.
: How do pharmacies seize opportunities? Arterial network: How will the national consumables collection of arrows change in the industry pattern on the strings? For more than a year, the policy on the procurement of consumables belt volume has been frequent.
end of July 2019, the General Office of the State Council issued the Reform Program for the Management of High-Value Medical Supplies, proposing to improve the centralized procurement methods for classification.
July 3, this year, the relevant departments issued a coronary bracket belt volume procurement-related program request for comments, crown stent became the first national collection varieties.
supplies of the national collection has been arrow in the string.
: Supplies collection curtain has opened.
: An important step for the payer to promote the reform of medical services is accompanied by the official launch of the reform of outpatient co-ordination and accounting, and there will be significant changes in the medical services and drug market.
reform will strengthen the existing market pattern on the medical service side, expand the size of the in-hospital market on the pharmaceutical side and narrow the size of the drug retail market.
if it is implemented with DRG, medical expenses will continue to be transferred from inpatient to outpatient, it is clear that the account can not bear the scale of this transfer, outpatient co-ordination is also the main tool to solve this problem.
, although the size of the clinic will continue to expand over the next 10 years.
but that doesn't mean the spring of primary clinics, the biggest gainer in this market is still level three hospitals.
: Big hospitals have an advantage in hospitalization.